The Non-Specific Drp1 Inhibitor Mdivi-1 Has Modest Biochemical Antioxidant Activity

Mitochondrial division inhibitor-1 (mdivi-1), a non-specific inhibitor of Drp1-dependent mitochondrial fission, is neuroprotective in numerous preclinical disease models. These include rodent models of Alzheimer’s disease and ischemic or traumatic brain injury. Among its Drp1-independent actions, th...

Full description

Bibliographic Details
Main Authors: Evan A. Bordt, Naibo Zhang, Jaylyn Waddell, Brian M. Polster
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Antioxidants
Subjects:
Online Access:https://www.mdpi.com/2076-3921/11/3/450
_version_ 1797447278770782208
author Evan A. Bordt
Naibo Zhang
Jaylyn Waddell
Brian M. Polster
author_facet Evan A. Bordt
Naibo Zhang
Jaylyn Waddell
Brian M. Polster
author_sort Evan A. Bordt
collection DOAJ
description Mitochondrial division inhibitor-1 (mdivi-1), a non-specific inhibitor of Drp1-dependent mitochondrial fission, is neuroprotective in numerous preclinical disease models. These include rodent models of Alzheimer’s disease and ischemic or traumatic brain injury. Among its Drp1-independent actions, the compound was found to suppress mitochondrial Complex I-dependent respiration but with less resultant mitochondrial reactive oxygen species (ROS) emission compared with the classical Complex I inhibitor rotenone. We employed two different methods of quantifying Trolox-equivalent antioxidant capacity (TEAC) to test the prediction that mdivi-1 can directly scavenge free radicals. Mdivi-1 exhibited moderate antioxidant activity in the 2,2′-azinobis (3-ethylbenzothiazoline 6-sulfonate) (ABTS) assay. Half-maximal ABTS radical depletion was observed at ~25 μM mdivi-1, equivalent to that achieved by ~12.5 μM Trolox. Mdivi-1 also showed antioxidant activity in the α, α-diphenyl-β-picrylhydrazyl (DPPH) assay. However, mdivi-1 exhibited a reduced capacity to deplete the DPPH radical, which has a more sterically hindered radical site compared with ABTS, with 25 μM mdivi-1 displaying only 0.8 μM Trolox equivalency. Both assays indicate that mdivi-1 possesses biochemical antioxidant activity but with modest potency relative to the vitamin E analog Trolox. Future studies are needed to evaluate whether the ability of mdivi-1 to directly scavenge free radicals contributes to its mechanisms of neuroprotection.
first_indexed 2024-03-09T13:53:37Z
format Article
id doaj.art-f480accc42d24238a1b13004d5ad3753
institution Directory Open Access Journal
issn 2076-3921
language English
last_indexed 2024-03-09T13:53:37Z
publishDate 2022-02-01
publisher MDPI AG
record_format Article
series Antioxidants
spelling doaj.art-f480accc42d24238a1b13004d5ad37532023-11-30T20:47:27ZengMDPI AGAntioxidants2076-39212022-02-0111345010.3390/antiox11030450The Non-Specific Drp1 Inhibitor Mdivi-1 Has Modest Biochemical Antioxidant ActivityEvan A. Bordt0Naibo Zhang1Jaylyn Waddell2Brian M. Polster3Center for Shock, Trauma and Anesthesiology Research, Department of Anesthesiology, University of Maryland School of Medicine, Baltimore, MD 21201, USACenter for Shock, Trauma and Anesthesiology Research, Department of Anesthesiology, University of Maryland School of Medicine, Baltimore, MD 21201, USADepartment of Pediatrics, University of Maryland School of Medicine, Baltimore, MD 21201, USACenter for Shock, Trauma and Anesthesiology Research, Department of Anesthesiology, University of Maryland School of Medicine, Baltimore, MD 21201, USAMitochondrial division inhibitor-1 (mdivi-1), a non-specific inhibitor of Drp1-dependent mitochondrial fission, is neuroprotective in numerous preclinical disease models. These include rodent models of Alzheimer’s disease and ischemic or traumatic brain injury. Among its Drp1-independent actions, the compound was found to suppress mitochondrial Complex I-dependent respiration but with less resultant mitochondrial reactive oxygen species (ROS) emission compared with the classical Complex I inhibitor rotenone. We employed two different methods of quantifying Trolox-equivalent antioxidant capacity (TEAC) to test the prediction that mdivi-1 can directly scavenge free radicals. Mdivi-1 exhibited moderate antioxidant activity in the 2,2′-azinobis (3-ethylbenzothiazoline 6-sulfonate) (ABTS) assay. Half-maximal ABTS radical depletion was observed at ~25 μM mdivi-1, equivalent to that achieved by ~12.5 μM Trolox. Mdivi-1 also showed antioxidant activity in the α, α-diphenyl-β-picrylhydrazyl (DPPH) assay. However, mdivi-1 exhibited a reduced capacity to deplete the DPPH radical, which has a more sterically hindered radical site compared with ABTS, with 25 μM mdivi-1 displaying only 0.8 μM Trolox equivalency. Both assays indicate that mdivi-1 possesses biochemical antioxidant activity but with modest potency relative to the vitamin E analog Trolox. Future studies are needed to evaluate whether the ability of mdivi-1 to directly scavenge free radicals contributes to its mechanisms of neuroprotection.https://www.mdpi.com/2076-3921/11/3/450ROSoxidative stressfree radicalscavengersuperoxideoxygen
spellingShingle Evan A. Bordt
Naibo Zhang
Jaylyn Waddell
Brian M. Polster
The Non-Specific Drp1 Inhibitor Mdivi-1 Has Modest Biochemical Antioxidant Activity
Antioxidants
ROS
oxidative stress
free radical
scavenger
superoxide
oxygen
title The Non-Specific Drp1 Inhibitor Mdivi-1 Has Modest Biochemical Antioxidant Activity
title_full The Non-Specific Drp1 Inhibitor Mdivi-1 Has Modest Biochemical Antioxidant Activity
title_fullStr The Non-Specific Drp1 Inhibitor Mdivi-1 Has Modest Biochemical Antioxidant Activity
title_full_unstemmed The Non-Specific Drp1 Inhibitor Mdivi-1 Has Modest Biochemical Antioxidant Activity
title_short The Non-Specific Drp1 Inhibitor Mdivi-1 Has Modest Biochemical Antioxidant Activity
title_sort non specific drp1 inhibitor mdivi 1 has modest biochemical antioxidant activity
topic ROS
oxidative stress
free radical
scavenger
superoxide
oxygen
url https://www.mdpi.com/2076-3921/11/3/450
work_keys_str_mv AT evanabordt thenonspecificdrp1inhibitormdivi1hasmodestbiochemicalantioxidantactivity
AT naibozhang thenonspecificdrp1inhibitormdivi1hasmodestbiochemicalantioxidantactivity
AT jaylynwaddell thenonspecificdrp1inhibitormdivi1hasmodestbiochemicalantioxidantactivity
AT brianmpolster thenonspecificdrp1inhibitormdivi1hasmodestbiochemicalantioxidantactivity
AT evanabordt nonspecificdrp1inhibitormdivi1hasmodestbiochemicalantioxidantactivity
AT naibozhang nonspecificdrp1inhibitormdivi1hasmodestbiochemicalantioxidantactivity
AT jaylynwaddell nonspecificdrp1inhibitormdivi1hasmodestbiochemicalantioxidantactivity
AT brianmpolster nonspecificdrp1inhibitormdivi1hasmodestbiochemicalantioxidantactivity